Ralph Raymond

Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function

Kevan C. Herold, Stephen E. Gitelman, Peter A. Gottlieb et al. · Diabetes Care · 2023 · 102 citations · Full text

Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study

Christophe Cellier, Gerd Bouma, Tom van Gils et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 96 citations · Full text

Gastroenterology, Clinical Trials, Type 2 +5

Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects

Lee K. Tay, Francisco León, George Vratsanos et al. · Arthritis Research & Therapy · 2007 · 93 citations · Full text

Transitional cell carcinoma of the renal pelvis or ureter: Patterns of failure

Scott C. Cozad, Stephen R. Smalley, Mark S. Austenfeld et al. · Urology · 1995 · 82 citations

Urological Research, Urology, Surgical Oncology +9

Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series

Sudha S. Shankar, Adrian Vella, Ralph Raymond et al. · Diabetes Care · 2016 · 73 citations · Full text